Neurodiagnostics Market: Is 2026 the Year Brain Biomarkers Finally Crack the Alzheimer's Diagnosis Code?
The global quest for accessible, accurate, and early Alzheimer's disease diagnosis is entering its most promising phase in 2026, with blood-based biomarker platforms, advanced neuroimaging techniques, and AI-powered cognitive assessment tools converging to create a multi-dimensional diagnostic ecosystem that offers the realistic prospect of identifying Alzheimer's pathology years before...
0 Kommentare 0 Geteilt 7 Ansichten 0 Bewertungen